day 1 agenda
Thu , Jul 18, 2019
- 08:00
-
Registrations
- 9:15
-
-
Introdunction to Organising committe members
- 9:30
-
-
Group photo
- 9:40
-
-
Keynote Session- Comprehensive proteomics analysis of breast cancer cell lines as it relates to targeted osmotic lysis
Harry J Gould, III, LSU Health Sciences Center, USA
- 10:10
-
-
Refreshments
- 10:30
-
-
Keynote Session - Application of ASTRO suitability criteria and 21-gene recurrence score results in breast cancer patients treated with intraoperative radiation therapy
Barb schwartzberg, Sarah Cannon Research Institute, USA
- 11:00
-
-
Keynote Session- Mammographic Density, Circadian Clocks, and Breast Cancer
Charles H. Streuli, Manchester Breast Centre, University of Manchester, UK
- 11:30
-
-
Scientific Session: Current Status of Korean Breast Cancer and New Technic Oncoplastic Surgery for Breast Cancer
Nam-Sun Paik, Ewha Womans University Cancer Center Hospital for Women, South Korea
- 11:50
-
-
Scientific Session- The impact of chemotherapy modification on the outcomes of breast and ovarian cancer patients
Sigita Liutkauskiene, Lithuanian University of Health Sciences, Oncology Institute, Lithuania
- 13:00
-
-
Lunch with Round table Discussions
- 14:00
-
-
Title: Inhibition of Na+/K+ ATPase activity inhibits the proliferation, motility, and invasion of endocrine resistant breast cancer cells
Maitham Khajah, Kuwait University, kuwait
- 14:20
-
-
Title: Breaking breast cancer news” with ethnic minority: a UK experience
Salma Naseem, UK
- 15:00
-
-
Title: Is Axillary Web Syndrome a Risk Factor for Lymphedema?
Pedro Ferreira, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Portugal
- 16:00
-
-
Refreshments
- 16:15
-
-
Speaker slot available
- 17:00
-
-
Panel Discussion
day 2 agenda
Fri , Jul 19, 2019
- 08:00
-
-
Registrations
- 9:30
-
-
Keynote Session- L-thyroxine's actions at a cell surface receptor on integrin alphavbeta3--on breast cancers of various types
Paul J. Davis, Albany Medical College, USA
- 10:00
-
-
Keynote Session - Update on Potential Biomarkers in Triple Negative Breast Cancer
Yan Peng, UT Southwestern Medical Center, USA
- 10:30
-
-
Refreshments
- 10:45
-
-
Title: Isolated thoracic perfusion in lung metastases from breast cancer
Stefano GUADAGNI, University of L’Aquila, Italy
- 11:15
-
-
Plenary Session
- 11:40
-
-
Scientific Session - Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy
Zigang li, Peking University Shenzhen Graduate School, China
- 12:15
-
-
Scientific Session - Potential value of PHLDA gene family members as a prognostic and predictive biomarker in breast cancer
Nagai, Maria Aparecida, Universidade de São Paulo, Brazil
- 12:45
-
-
Scientific Session- Abscopal Effect of Breast Cancer
Azami Ayaka, Southern TOHOKU General Hospital, Japan
- 13:15
-
-
Lunch with Round table Discussions
- 14:00
-
-
Poster Presentation
- 15:10
-
-
Scientific Session- Association of miR‐1247‐5p expression with clinicopathological parameters and prognosis in breast cancer
Peng Zhang, Peking University Shougang Hospital, China
- 15:30
-
-
Scientific Session- Introducing novel and comprehensive models for the prediction of recurrence in breast cancer using group LASSO approach: are estimates of early and late recurrence different?
Tannaz Eghbali, Shiraz University of Medical sciences
- 15:50
-
-
Scientific Session- Treatment with non-steroidal anti-inflammatory drugs effectively cause a reduction in risk and recurrence of BRCA
TMU, sc.chang, Taipei Medical University,Taiwan
- 16:15
-
-
Refreshments
- 16:30
-
-
Speaker slot available
- 16:50
-
-
Plenary Session
- 17:15
-
-
Panel Discussion
day 3 agenda
Sat , Jul 20, 2019
- 09:00
-
-
Scientific Sessions
- 10:00
-
-
Refreshments
- 10:30
-
-
Scientific Sessions
- 13:00
-
-
Lunch with Round table Discussions
- 14:00
-
-
Scientific Sessions
-
-
Panel Discussion